ASCENTAGE PHARMA GROUP INTLASCENTAGE PHARMA GROUP INTLASCENTAGE PHARMA GROUP INTL

ASCENTAGE PHARMA GROUP INTL

No trades
See on Supercharts

6855 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
6855 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company